AMNISURE FMRT-1 FMRT-1-10-ML-RT

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 07 report with the FDA on 2015-03-30 for AMNISURE FMRT-1 FMRT-1-10-ML-RT manufactured by Amnisure International, Llc.

Event Text Entries

[16880627] Adverse event reported by distributor in (b)(6) on (b)(6) 2015. Approximately two months prior to reporting this adverse event, a patient arrived at her ob/gyn complaining of discharge. The patient was at a gestational age of (b)(6) weeks and was carrying twins. An amnisure test was performed and the result was negative. The patient was sent home. The patient returned to the hospital 5 days later complaining of continued discharge. Another amnisure test was performed and the result was again negative. A sonogram was performed and showed a very low afi. A cesarean section was then performed and both fetus' were deceased. The physician was not claiming that there was a false negative result with this incident. The physician stated that there was uncertainty as to whether the patient was ruptured and the low afi may have been due to other clinical conditions.
Patient Sequence No: 1, Text Type: D, B5


[17191960] The company is unable to obtain information to further investigate this event due to a holiday in (b)(6). The company is submitting this mdr in compliance with 21 cfr part 803. The company will supplement this mdr with additional information, as necessary. Our preliminary investigation has identified the following: a) the intended use of the amnisure rom test, as written in the package insert, indicates that the test is an aid in the detection of rupture of fetal membranes (rom) in pregnant women. As a diagnostic aid, there is an expectation that patient care is based on a multitude of factors/tests/analyses. In this case, an initial ultrasound would have been useful as an additional tool in determining rom status and clinical actions. B) the attending physician was unable to confirm that the patient had been leaking amniotic fluid. Due to the patient's condition there may have been other clinical factors that attributed to her low amniotic fluid level, thus amnisure would have provided correct results. C) the company performed testing on retain samples for the lots implicated and all results passed specifications. Additionally, batch records were reviewed and all testing passed specifications with no deviations noted.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3005345832-2015-00002
MDR Report Key4651981
Report Source07
Date Received2015-03-30
Date of Report2015-03-24
Date Mfgr Received2015-03-09
Device Manufacturer Date2014-04-01
Date Added to Maude2015-04-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactDONNA SOWERS
Manufacturer Street19300 GERMANTOWN ROAD
Manufacturer CityGERMANTOWN MD 20874
Manufacturer CountryUS
Manufacturer Postal20874
Manufacturer Phone2406867876
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameAMNISURE
Generic NameRAPID FETAL MEMBRANES RUPTURE TEST
Product CodeNQM
Date Received2015-03-30
Model NumberFMRT-1
Catalog NumberFMRT-1-10-ML-RT
Lot NumberA354525, A355744
ID NumberNA
Device Expiration Date2016-11-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerAMNISURE INTERNATIONAL, LLC
Manufacturer Address24 SCHOOL STREET, 6TH FLOOR BOSTON MA 02108 US 02108


Patients

Patient NumberTreatmentOutcomeDate
101. Death 2015-03-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.